This site is intended for health professionals only!

Published on 1 November 2007

Share this story:

The role of docetaxel (Taxotere) in head and neck squamous cell carcinoma (HNSCC) management


In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine